Mice with CRC colonized with either tumor‐promoting bacteria or probiotics exhibited positive responses to LipoAgTNZ treatment, leading to a long‐term survival rate exceeding 70% in two CRC models infected with Fn. The gene discussed is FN1; the disease is colorectal carcinoma.